LONDON (AP) _ Advanz Pharma (CXRXF) on Wednesday reported fourth-quarter net income of $2.4 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the London-based company said it had net income of 5 cents. Losses, adjusted for one-time gains and costs, came to 35 cents per share.

The pharmaceutical company posted revenue of $135 million in the period.

For the year, the company reported that its loss narrowed to $74.9 million, or $1.53 per share. Revenue was reported as $525.6 million.

Advanz Pharma shares have climbed fivefold since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $16.55, a drop of almost 10% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CXRXF at https://www.zacks.com/ap/CXRXF

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News